News tagged with 'Vytorin'

It is unlikely that cholesterol drug, Vytorin, and related drug, Zetia, raise the risk of cancer. That is the good news for Merck & Co. from the FDA which adds that a link cannot be ruled out until ongoing research is concluded.

Zetia did not do as well in reducing plaque in the artery wall of the neck as the simple B vitamin, niacin, in this published study, which was curtailed early because of the results.

This second look at the data says that not as many children should be put on statins to lower cholesterol as the American Association of Pediatrics origionally recommended.  

Use the cholesterol lowering drug Vytorin with caution - that's the advice of editors of a leading medical journal after published reports link the drug to cancer deaths in a three-study analysis that was supposed to put to rest any concerns. 

Food and Drug Administrators are reviewing data that suggests a higher rate of cancer in patients taking the cholesterol-lowering drug Vytorin. Patients are advised to continue taking Vytorin because the cancer link is unclear at this time.

Vytorin, despite a $200 million advertising campaign does nothing to reduce heart disease it was announced at a cardiology conference this weekend.  Meanwhile it has healthy sales of $5 billion for Merck and Schering-Plough.